Get the full picture
Sign in to uncover key details.
SpliSense
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
The Hebrew University of Jerusalem Edmon...Phone Number
+972 528367731Website
www.splisense.comRevenue
<$5 MillionIndustry
About SpliSense
SpliSense specializes in innovative RNA-based therapies utilizing Antisense Oligonucleotides (ASOs) to address the root causes of pulmonary diseases. Their treatments aim to restore and modify protein functionality, targeting conditions that are currently untreatable. The company focuses on diseases such as cystic fibrosis and muco obstructive pulmonary diseases, with a pipeline that includes various therapeutic candidates. SpliSense is dedicated to transforming the landscape of pulmonary disease treatment through advanced RNA technology.Explore more
SpliSense Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
SpliSense Tech Stack
A closer look at the technologies used by SpliSense
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SpliSense
Sign Up For FreeTo access detailed company insights
SpliSense specializes in innovative RNA-based therapies utilizing Antisense Oligonucleotides (ASOs) to address the root causes of pulmonary diseases. Their treatments aim to restore and modify protein functionality, targeting conditions that are currently untreatable. The company focuses on diseases such as cystic fibrosis and muco obstructive pulm... Read More
